Related references
Note: Only part of the references are listed.Impact of rejection-related immune responses on the initiation and progression of cardiac allograft vasculopathy
Michael Dandel et al.
AMERICAN HEART JOURNAL (2020)
Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation A Population-Based Study
Alexandre Loupy et al.
CIRCULATION (2020)
Predicting Where Patients Will Be, Rather Than Just Seeing Where They Are Establishing Trajectories of Cardiac Allograft Vasculopathy
Yasbanoo Moayedi et al.
CIRCULATION (2020)
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 23rd pediatric heart transplantation report-2020; focus on deceased donor characteristics
Tajinder P. Singh et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)
Surveillance for cardiac allograft vasculopathy: Practice variations among 50 pediatric heart transplant centers
Deipanjan Nandi et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-second pediatric heart transplantation report-2019; Focus theme: Donor and recipient size match
Joseph W. Rossano et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2019)
Cardiac allograft vasculopathy and graft failure in pediatric heart transplant recipients after rejection with severe hemodynamic compromise
Jake A. Kleinmahon et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2019)
Shedding Light on Cardiac Allograft Vasculopathy OCT to Predict Progression of Disease
David A. Baran
JACC-CARDIOVASCULAR IMAGING (2017)
Changes in Outcomes of Cardiac Allograft Vasculopathy Over 30 Years Following Heart Transplantation
Maxime Tremblay-Gravel et al.
JACC-HEART FAILURE (2017)
Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation
Andrew Tran et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2016)
Allograft Vasculopathy The Achilles' Heel of Heart Transplantation
Sharon Chih et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Improved Detection of Cardiac Allograft Vasculopathy A Multi-Institutional Analysis of Functional Parameters in Pediatric Heart Transplant Recipients
Steven J. Kindel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Circulating Donor-Specific Anti-Human Leukocyte Antigen Antibodies and Complement C4d Deposition Are Associated With the Development of Cardiac Allograft Vasculopathy
Renee Frank et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
Differential Effect of Everolimus on Progression of Early and Late Cardiac Allograft Vasculopathy in Current Clinical Practice
M. Masetti et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Attenuation of cardiac allograft vasculopathy by sirolimus: Relationship to time interval after head transplantation
Yoshiki Matsuo et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2013)
Donor-Specific Antibodies to Class II Antigens Are Associated With Accelerated Cardiac Allograft Vasculopathy: A Three-Dimensional Volumetric Intravascular Ultrasound Study
Yan Topilsky et al.
TRANSPLANTATION (2013)
Rejection with hemodynamic compromise in the current era of pediatric heart transplantation: A multi-institutional study
Melanie D. Everitt et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2011)
International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010
Mandeep R. Mehra et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)
Cardiac allograft vasculopathy - Recent developments
Daniel Schmauss et al.
CIRCULATION (2008)
The impact and outcome of transplant coronary artery disease in a pediatric population: A 9-year multi-institutional study
E Pahl et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years - A randomized clinical trial
A Keogh et al.
CIRCULATION (2004)
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients
HJ Eisen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Rapamycin inhibits vascular remodeling in an experimental model of allograft vasculopathy and attenuates associated changes in fibrosis-associated gene expression
GJ Murphy et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2003)
Share Paper
